Exascale Labs Holdings Inc. (XLAB)

NASDAQ: XLAB · USD

$2.18

+0.14 (+6.9%)· Recorded snapshot

Market cap	198.8M
Revenue (ttm)	14.8M
Net income (ttm)	-12.2M
Shares out	91.2M
Volume	505,667.95

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 14.8M
Net income (ttm): -12.2M
Market cap: 198.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 13.4P50 19.8P75 31.4

Trailing P/En/a

P25 16.8P50 29.9P75 54

ROEn/a

P25 -35.5P50 1.5P75 15.4

ROICn/a

P25 -18.6P50 1.9P75 14.1

Benchmarks · 1M

All XLAB indicators

Market & fundamental data

Available fields

165

Groups with data

Currency

USD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0002109869
Company name	Exascale Labs Holdings Inc.
Country	United States
Country code	US
CUSIP number	30066G102
Earnings date	2026-12-15
Earnings time	amc
Employees	10
Enterprise value	$196.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-08-30
Fiscal year end	June
Industry	Software - Infrastructure
Is primary listing	Yes
Is SPAC	No
ISIN number	US30066G1022
Last 10-K release date	2026-09-28
Last earnings date	2026-09-28
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$198.8M
Market cap category	Micro-Cap
Next earnings date	2026-12-15
Options	No
Price	$2.18
Price currency	USD
Sector	Technology
SIC code	7372
Stock price date	2026-11-03
Symbol	XLAB
U.S. state	Texas
Website	https://www.exascalelabs.ai

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-6.12%
EV/Sales	13.23x
FCF / EV yield	-2.05%
FCF yield	-2.02%
Industry forward P/E	26.42x
Industry P/E	34.4x
P/S ratio	13.41x
Sector forward P/E	16.89x
Sector P/E	28.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-32.39%
EBITDA margin	-32.34%
Gross margin	16.31%
Operating margin	-32.39%
Pretax margin	-82.05%
Profit margin	-82.05%
Profit per employee	$-1.2M
Revenue per employee	$1.5M
ROA	-42.71%
ROCE	19.08%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	118.81%
Gross profit growth (Q)	66.37%
Net income growth years	0
Revenue growth	111.29%
Revenue growth (Q)	67.8%
Revenue growth (QoQ)	13.5%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$6,925
EBIT	$-4.8M
EBITDA	$-4.8M
FCF per share	$-0.04
Financing cash flow	$-95,000
Free cash flow	$-4M
Gross profit	$2.4M
Investing cash flow	$606,752
Net cash flow	$-3.5M
Net income	$-12.2M
Operating income	$-4.8M
Revenue	$14.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-4.36
Long-term assets	$202,840
Long-term liabilities	$0
Net cash (debt)	$2.7M
Net cash / market cap	1.35%
Net cash growth	-36.35%
Piotroski F-Score	3
Property, plant and equipment	$12,840
Shareholders' equity	$-25.2M
Tangible book value	$-25.2M
Total assets	$6.7M
Total cash	$2.7M
Total debt	$0
Total liabilities	$31.9M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	2.11
Current assets	$6.5M
Current liabilities	$31.9M
Current ratio	0.2
Net working capital	$-28.1M
Quick ratio	0.12
Working capital	$-25.4M
Working capital turnover	-0.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$7.22
1D price change	6.86%
1M price change	55.71%
1M total return	55.71%
1W price change	-29.22%
1W total return	-29.22%
1Y price change	-78.31%
1Y return CAGR	-78.33%
1Y total return	-78.31%
20-day SMA	$2.31
200-day SMA	$7.95
3M price change	-57.09%
3M total return	-57.09%
50-day SMA	$2.92
50-day SMA vs 200-day SMA	50under200
52-week high	$11.17
52-week high date	2026-06-03
52-week low	$0.78
52-week low date	2026-10-15
6M price change	-78.67%
6M total return	-78.67%
After-hours change	0.46%
After-hours close	$2.18
After-hours price	$2.19
All-time high	$11.17
All-time high date	2026-06-03
All-time low	$0.78
All-time low date	2026-10-15
Average true range (ATR)	$0.64
Average volume	17.7M
Beta (1Y)	-2.59
Beta (2Y)	-2.31
Change from 52-week high	-80.48%
Change from 52-week low	180.31%
Change from all-time high	-80.48%
Change from all-time low	180.31%
Change from open	-1.36%
Day's gap	8.33%
Dollar volume	$1.1M
High price	$2.36
Low price	$2.10
Monthly RSI	24.52
Open price	$2.21
Position in 52-week range	30.77%
Premarket change	-2.29%
Premarket close	$2.18
Premarket price	$2.13
Premarket volume	12.2K
Previous close	$2.04
Price vs 150-day SMA	-69.81%
Price vs 20-day SMA	-5.71%
Price vs 200-day SMA	-72.58%
Price vs 50-day SMA	-25.27%
Relative volume	0.03
RSI	45.07
Sharpe ratio	-0.4
Sortino ratio	-0.67
Volume	505.7K
Weekly RSI	29.94
YTD price change	-78.27%
YTD total return	-78.27%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	60.5M
Float percentage	66.29%
Shares held by institutions	0.04%
Shares outstanding	91.2M
Short % of float	0.06%
Short % of shares	0.04%
Short ratio	0.1 days

Deeper analysis on XLAB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this XLAB report

Is a complete XLAB research report available?

No complete published report is available for Exascale Labs Holdings Inc. (XLAB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Exascale Labs Holdings Inc. (XLAB)

Price

Financial snapshot

Fair-value bridge

Latest news · XLAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XLAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on XLAB

Frequently asked questions